Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **MIR124-2 host gene** (MIR124-2HG) is a human long non-coding RNA (lncRNA) gene located on chromosome 8 and also known as LINC00966. It functions primarily as a non-protein coding RNA and serves as a host gene for the microRNA miR-124-2. MIR124-2HG is involved in regulating gene expression through mechanisms such as influencing mRNA translation, modulating signaling pathways, and controlling processes critical for neural development and cellular differentiation. It is also implicated in immune regulation and has emerging associations with diseases such as neurodegenerative diseases and certain cancers, likely through its regulatory influence on its embedded microRNA and related pathways[1][3][2][5]. This gene is not a conventional therapeutic target like a receptor or enzyme, and there are no known drugs that specifically interact with MIR124-2HG as a target. There are currently no established biomarkers or specific safety concerns directly related to manipulation of MIR124-2HG.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR124-2 host gene (MIR124-2HG).